People: Board
David A. Gough
Chief Executive Officer
Click here for full biography.
Dr. Anthony D. Baxter
Non-executive Chairman
Dr. Baxter CChem, FRSC is the current CEO of Cyprotex plc and was formerly CEO of deltaDOT, which specialises in high quality productivity tools for drug discovery. He has over 22 years experience in management and research within the pharmaceutical, biotech chemistry service and instrumentation industries, mainly in the areas of drug discovery, medicinal chemistry, combinatorial chemistry and compound synthesis.
Before joining deltaDOT he was: one of the founders and CEO of Argenta Discovery Ltd, a specialist medicinal chemistry company providing world-class services to the pharmaceutical industry; CSO of Oxford Asymmetry International Ltd (1999-2000) where he set up and managed the Discovery Services Division; Director of Combinatorial Chemistry at Oxford Diversity Ltd (1994-1999); Research Manager at Ciba UK Central Research Laboratories (1990-1994) where he managed Ciba blue-sky research interests; Team Leader at Glaxo Group Research (1983-1990). He has notable scientific success in assisting the development of marketed drugs, Lotronex, Abacavir, Lamivudine and in the discovery of advanced clinical development candidates for Curis, Serono, GSK, Ciba and Argenta.
Dr. Baxter completed his PhD with Prof. Stan Roberts on prostaglandin chemistry at Salford University. His main interests are the development of new chemical entities, particularly antivirals and in metabolic disease, new chemical technologies including solid phase synthesis and robotics, and antisense and carbohydrate chemistry.
Professor Paul S. Freemont
Non-executive Director and co-founder
Professor Freemont BSc, PhD is the head of the Molecular Biosciences Division and holds the Chair of Protein Crystallography at Imperial College. His previous posts were: Director of the Imperial College Centre for Structural Biology, Head of Molecular Structure and Function Laboratory, Cancer Research UK (1988-2000); Postdoctoral research fellow in the Department of Molecular Biophysics and Biochemistry at Yale University (1984-1988) and graduate student at University of Aberdeen (1980-1984).
His research interests are in determining relationships between macromolecular structure and function using experimental methods that include protein crystallography, NMR and Cryo-Electron Microscopy. He has over 100 refereed papers.
Professor Stephen H. Muggleton
Non-executive Director and co-founder
Professor Muggleton BSc, PhD, FAAAI, FRSA is the Director of the Imperial College Computational Bioinformatics Laboratory, Director of Modelling at the Centre for Integrative Systems Biology at Imperial College (CISBIC) and holds the Joint Research Council Chair of Computational Bioinformatics at Imperial College. His previous posts were: Chair of Machine Learning, University of York (1997-2001); Reader in Machine Learning, EPSRC Advanced Research Fellow and Head of the Machine Learning Group, Computing Laboratory, University of Oxford (1992-1997); EPSRC Post-doctoral Fellow and Turing Institute Research Fellow at the Turing Institute, Glasgow (1986-1992).
His research interests are related to the development of general, logic-based approaches to machine learning, especially with applications to predictive modelling problems in Biology.
Professor Michael J.E. Sternberg
Non-executive Director and co-founder
Professor Sternberg MA, MSc, DPhil, CBiol, FIBiol is the Director of the Imperial College Centre for Bioinformatics and holds the Chair of Structural Bioinformatics at Imperial College. His previous posts were: Head of Biomolecular Modelling Laboratory, Cancer Research UK (1988-2001); Lecturer and Research Fellow in the Crystallography Department, Birkbeck College (1983-1988); and Postdoctoral and Graduate research in Oxford (1974-1983).
His research interest is the development of novel approaches and principles for the computer modelling of biomolecular structure and function.
